Clinical Trial On Kosta chooranam For The Management Of Melasma (Mangu )

Clinical Evalution Of Kosta Chooranam as External Medicine For The Management Of Mangu (Melasma)

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/05/019371

Enrollment

Registered

2019-05-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L819- Disorder of pigmentation, unspecified

Interventions

Intervention1: Kosta Chooranam: Quantity Sufficient. Mix 1 tablespoon of Kosta Chooranam with 1 tablespoon of Honey and leave it on for 20 minutes on the affected area.Rinse it off with water(external

Eligibility

Inclusion criteria

Inclusion criteria: Typical distribution of the lesion on the face, Willing to participate in the trial and sign the informed consent, willing to give blood and urine sample for laboratory investigation, patient willing to photograph before and after treatment

Exclusion criteria

Exclusion criteria: Pregnancy and Lactation STD Leprosy Burns HIv Patients with other serious illness

Design outcomes

Primary

Measure	Time frame
primary outc ome is assessed by pigmentation of the skin scaleTimepoint: 48 days	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDr K Petchiammal

Tamilnadu Dr MGR Medical University

svisu11@gmail.com9962542755

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026